Effects of interleukin-1β on sleep are mediated by the type I receptor

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 274, Issue 3 43-3, 1998, Pages

  Fang, Jidong ^a   Wang, Ying ^a   Krueger, James M ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Interleukin 1 receptor; Knockout mice; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DARKNESS; MALE; NONHUMAN; NONREM SLEEP; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; RAT; REM SLEEP;

EID: 0031945485     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1998.274.3.r655     Document Type: Article

References (50)

1. Aeschbach, D., D.-J. Dijk, L. Trachsel, D. P. Brunner, and A. A. Borbély. Dynamics of slow-wave activity and spindle frequency activity in the human sleep EEG: effect of midazolam and zopiclone. Neuropsychopharmacology 11: 237-244, 1994.
2. 2 production in resting macrophages. Biochem. Biophys. Res. Commun. 136: 94-101, 1986.
3. Ban, E. M. Interleukin-1 receptors in the brain: characterization by quantitative in situ autoradiography. Immunomethods 5: 31-40, 1994.
4. Berridge, C. W., and S. L. Foote. Effects of locus coeruleus activation on electroencephalographic activity in neocortex and hippocampus. J. Neurosci. 11: 3135-3145, 1991.
5. Borbély, A. A. A two process model of sleep regulation. Hum. Neurobiol. 1: 195-204, 1982.
6. Borbély, A. A., P. Mattmann, M. Loepfe, I. Strauch, and D. Lehmann. Effects of benzodiazepine hypnotics on all-night sleep EEG spectra. Hum. Neurobiol. 4: 189-194, 1985.
7. Borbély, A. A., and I. Tobler. Endogenous sleep-promoting substances and sleep regulation. Physiol. Rev. 69: 605-670, 1989.
8. Brunner, D. P., D.-J. Dijk, M. Münch, and A. A. Borbély. Effects of zolpidem on sleep and sleep EEG spectra in healthy young men. Psychopharmacology (Berl.) 104: 1-5, 1991.
9. Colotta, F., S. K. Dower, J. E. Sims, and A. Mantovani. The type II "decoy" receptor. A novel regulatory pathway for interleukin-1. Immunol. Today 15: 562-566, 1994.
10. Cunningham, E. T., Jr., and E. B. De Souza. Interleukin-1 receptors in the brain and endocrine tissues. Immunol. Today 14: 171-174, 1993.
11. Cunningham, E. T., Jr., E. Wada, D. B. Carter, D. E. Tracey, J. F. Battey, and E. B. De Souza. In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary, and adrenal gland of the mouse. J. Neurosci. 12: 1101-1114, 1992.
12. Dinarello, C. A. Interleukin-1 and interleukin-1 antagonism. Blood 77: 1627-1652, 1991.
13. Dinarello, C. A., J. G. Cannon, S. M. Wolff, H. A. Bernheim, B. Beutler, A. Cerami, I. S Figari, M. A. Palladino, Jr., and J. V. O'Connor. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J. Exp. Med. 163: 1433-1450, 1986.
14. Dunn, A. J. Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism paralleling the increased plasma corticosterone. Life Sci. 43: 429-435, 1988.
15. Dunn, A. J. Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism: comparison with interleukin-1. J. Pharmacol. Exp. Ther. 261: 964-969, 1992.
16. Ehlers, C. L., T. K. Reed, and S. J. Henriksen. Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats. Neuroendocrinology 11: 467-474, 1986.
17. Ericsson, A., C. Liu, R. P. Hart, and P. E. Sawchenko. Type I interleukin-1 receptor in the rat brain: distribution, regulation, and relationships to sites of IL-1-induced cellular activation. J. Comp. Neurol. 361: 681-698, 1995.
18. Fang, J., C. K. Sanborn, K. Renegar, J. A. Majde, and J. M. Krueger. Influenza viral infection induces sleep changes in mice. Proc. Soc. Exp. Biol. Med. 210: 242-251, 1995.
19. Fang, J., Y. Wang, and J. M. Krueger. Mice lacking the TNF 55-kD receptor fail to sleep more after TNFα treatment. J. Neurosci. 17: 5949-5955, 1997.
20. Friedman, E. M., S Boinski, and C. L. Coe. Interleukin-1 induces sleep-like behavior and alters call structure in juvenile rhesus macaques. Am. J. Primatol. 35: 145-153, 1995.
21. Gerlai, R. Gene targeting in neuroscience: the systemic approach. Trends Neurosci. 19: 188-189, 1996.
22. Gowen, M., K. Chapman, A. Littlewood, D. Hughes, D. Evans, and G. Russell. Production of tumor necrosis factor by human osteoblasts is modulated by other cytokines, but not by osteotropic hormones. Endocrinology 126: 1250-1255, 1990.
23. Hayaishi, O., and H. Matsumura. Prostaglandins and sleep. Adv. Neuroimmunol. 5: 211-216, 1995.
24. Hohagen, F., J. Timmer, A. Weyerbrock, R. Fritsch-Montero, U. Ganter, S. Krieger, M. Berger, and J. Bauer. Cytokine production during sleep and wakefulness and its relationship to cortisol in healthy humans. Neuropsychobiology 28: 9-16, 1993.
25. Krueger, J. M., and J. A. Majde. Microbial products and cytokines in sleep and fever regulation. Crit. Rev. Immunol. 14: 355-379, 1994.
26. Krueger, J. M., J. Walter, C. A. Dinarello, S. M. Wolff, and L. Chedid. Sleep-promoting effects of endogenous pyrogen (interleukin-1). Am. J. Physiol. 246 (Regulatory Integrative Comp. Physiol. 15): R994-R999, 1984.
27. Kushikata, T., J. Fang, Y. Wang, and J. M. Krueger. Interleukin-4 attenuates rabbits' spontaneous sleep. Soc Neurosci. Abstr. 23: 792, 1997.
28. Lancel, M., S. Mathias, J. Faulhaber, and T. Schiffelholz. Effect of interleukin-1 beta on EEG power density during sleep depends on circadian phase. Am. J. Physiol. 270 (Regulatory Integrative Comp. Physiol. 39): R830-R837, 1996.
29. Lue, F. A., M. Bail, J. Jephthah-Ocholo, K. Carayanniotis, R. Gorczynski, and H. Modofsky. Sleep and cerebrospinal fluid interleukin-1 like activity in the cat. Intern. J. Neurosci. 42: 179-183, 1988.
30. Mackiewicz, M., P. J. Sollars, M. D. Ogilvie, and A. I. Pack. Modulation of IL-1βgene expression in the rat CNS during sleep deprivation. Neuroreport 7: 529-533, 1996.
31. Miller, L. G., and J. M. Fahey. Interleukin-1 modulates GABAergic and glutamatergic function in brain. Ann. NY Acad. Sci. 31: 292-298, 1994.
32. Miller, L. G., W. R. Galpern, K. Dunlap, C. A. Dinarello, and T. J. Turner. Interleukin-1 auguments gamma-aminobutyric acid A receptor function in brain. Mol. Pharmacol. 39: 105-108, 1991.
33. Moldofsky, H., F. A. Lue, J. Eisen, E. Keystone, and R. M. Gorczynski. The relationship of interleukin-1 and immune functions to sleep in humans. Psychosom. Med. 48: 309-318, 1986.
34. Obal, F., Jr., J. Fang, L. Payne, and J. M. Krueger. Growth hormone-releasing hormone (GHRH) mediates the sleep-promoting activity of interleukin-1 (IL-1) in rats. Neuroendocrinology 61: 559-565, 1995.
35. Obal, F., Jr., L. Payne, L. Kapás, M. R. Opp, and J. M. Krueger. Inhibition of growth hormone-releasing factor suppresses both sleep and growth hormone secretion in the rat. Brain Res. 557: 149-153, 1991.
36. Opp, M. R., and J. M. Krueger. Anti-interleukin-1β reduces sleep and sleep rebound after sleep deprivation in rats. Am. J. Physiol. 266 (Regulatory Integrative Comp. Physiol. 35): R688-R695, 1994.
37. Opp, M. R., and J. M. Krueger. Interleukin-1 is involved in responses to sleep deprivation in the rabbit. Brain Res. 639: 57-65, 1994.
38. Opp, M. R., F. Obál, Jr., and J. M. Krueger. Interleukin-1 alters rat sleep: temporal and dose-related effects. Am. J. Physiol. 260 (Regulatory Integrative Comp. Physiol. 29): R52-R58, 1991.
39. Opp, M. R., E. M. Smith, and T. K. Hughes. Interleukin-10 acts in the central nervous system of rats to reduce sleep. J. Neuroimmunol. 60: 165-168, 1995.
40. Philip, R., and L. B. Epstein. Tumor necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1. Nature 323: 86-89, 1986.
41. Reinisch, N., M. Wolkersdorfer, C. M. Kahler, K. Ye, C. A. Dinarello, and C. J. Wiedermann. Interleukin-1 receptor type I mRNA in mouse brain as affected by peripheral administration of bacterial lipopolysaccharide. Neurosci. Lett. 166: 165-167, 1994.
42. Smagin, G. N., A. H. Swiergiel, and A. J. Dunn. Peripheral administration of interleukin-1 increases extracellular concentrations of norepinephrine in rat hypothalamus: comparison with plasma corticosterone. Psychoneuroendocrinology 21: 83-93, 1996.
43. Susie, V., and S. Totic. "Recovery" function of sleep: effects of purified human interleukin-1 on the sleep and febrile response of cats. Metab. Brain Dis. 4: 73-80, 1989.
44. Taishi, P., S. Bredow, N. Guha-Thakurta, F. Obál, Jr., and J. M. Krueger. Diurnal variations of interleukin-1β mRNA and β-actin mRNA in rat brain. J. Neuroimmunol. 75: 69-74, 1997.
45. Takahashi, S., J. Fang, L. Kapás, Y. Wang, and J. M. Krueger. Inhibition of brain interleukin-1 attenuates sleep rebound after sleep deprivation in rabbits. Am. J. Physiol. 273 (Regulatory Integrative Comp. Physiol. 42): R677-R682, 1997.
46. Takahashi, S., L. Kapás, J. Fang, Y. Wang, J. M. Seyer, and J. M. Krueger. An interleukin-1 receptor fragment inhibits spontaneous sleep and muramyl dipeptide-induced sleep in rabbits. Am. J. Physiol. 271 (Regulatory Integrative Comp. Physiol. 40): R101-R108, 1996.
47. 125I] recombinant human interleukin-1 receptor antagonist. J. Neuroimmunol. 41: 51-60, 1992.
48. 2 in interleukin-1-induced activation of norepinephrine turnover in the brain and peripheral organs of rats. J. Neurochem. 65: 2742-2747, 1995.
49. Tobler, I., A. A. Borbély, M. Schwyzer, and A. Fontana. Interleukin-1 derived from astrocytes enhances slow-wave activity in sleep EEG of the rat. Eur. J. Pharmacol. 104: 191-192, 1984.
50. Yabuuchi, K., M. Minami, S. Katsumata, and M. Satoh. Localization of type I interleukin-1 receptor mRNA in the rat brain. Mol. Brain Res. 27: 27-36, 1994.